“Covalent biosensing” enables a one-step, reagent-less, low-cost and highly robust assay of SARS-CoV-2†
Abstract
We have established a new protocol for detecting severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) using a peptidomimetic to covalently detect a viral marker protease.